Related Experiment Video
Updated: Sep 10, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Occurrence of coronary events in the absence of traditional risk factors: Understanding residual risk
Natalie Arnold1, Alina Goßling2, Jessica Weimann2
1Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Luebeck, Germany; Center for Population Health Innovation (POINT), University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Insights
Elevated triglycerides and high-sensitivity C-reactive protein (hsCRP) increase coronary heart disease (CHD) risk, even without traditional cardiovascular risk factors (CVRFs). These biomarkers aid residual risk assessment in metabolically healthy individuals.
Area of Science:
- Cardiology
- Biomarkers
- Epidemiology
Background:
- Predictors of coronary heart disease (CHD) events in individuals without traditional modifiable cardiovascular risk factors (CVRFs) are not fully understood.
- Residual risk assessment is crucial for identifying individuals at elevated risk despite the absence of conventional CVRFs.
Purpose of the Study:
- To investigate the association between circulating biomarkers and incident CHD in a general population.
- To determine if the association between biomarkers and CHD risk is modified by the presence of CVRFs (hypertension, diabetes mellitus, hypercholesterolemia, smoking, obesity).
Main Methods:
- Analysis of 212,598 CHD-free individuals from 21 European cohorts, stratified by CVRF burden (zero, one, or ≥2).
- Assessment of five biomarkers: triglycerides (TGs), high-sensitivity C-reactive protein (hsCRP), cystatin C, N-terminal pro-B-type natriuretic peptide, and high-sensitivity troponin I in a subset.
- Median follow-up of 13.97 years, with 17,499 incident CHD events recorded.
Main Results:
- All biomarkers were associated with increased incident CHD risk.
- Triglycerides (TGs) showed significant risk modulation by CVRFs (pinteraction<0.01).
- High-sensitivity C-reactive protein (hsCRP) demonstrated a trend towards risk modulation (pinteraction=0.092).
Conclusions:
- Elevated triglycerides and hsCRP are significantly associated with increased CHD risk, even in individuals without CVRFs.
- These findings underscore the importance of using TGs and hsCRP for residual risk assessment in metabolically healthy populations.
- Biomarker assessment can identify individuals at risk missed by conventional CVRF screening.
Background And Aims:
The major predictors of future coronary heart disease (CHD) events in individuals without traditional modifiable cardiovascular risk factors (CVRFs) remain unknown. We investigated the association between circulating biomarkers, reflecting residual risk, with incident CHD in a general population, according to the presence of five CVRFs (hypertension, diabetes mellitus, hypercholesterolemia, smoking and obesity) at baseline.
Methods:
Overall 212,598 CHD-free individuals from 21 European population-based cohorts were stratified by CVRF burden into three groups, having zero (n = 35,707), one (n = 68,548) or ≥2 (n = 108,343) risk factors at baseline. Five biomarkers (triglycerides (TGs), high-sensitivity C-reactive protein (hsCRP), cystatin C, N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin I) were assessed in a subset with available measurements.
Results:
During a median follow-up of 13.97 years, 17,499 participants developed incident CHD with 453 events occurring among individuals without CVRFs. Although increased concentrations of all biomarkers were related to incident CHD, significant risk modulation by CVRFs was seen only for TGs and, to a lesser extent, for hsCRP. The fully-adjusted sub-distribution Hazard Ratios (95 % CI) were for TGs (≥vs < 1.70 mmol/L) 1.66 (1.29-2.15) in those without CVRFs versus 1.35 (1.21-1.49)/1.14 (1.07-1.20) in those with 1 or ≥2 risk factors (pinteraction<0.01) and for hsCRP (≥vs < 2 mg/L) 1.39 (1.02-1.90) versus 1.42 (1.26-1.61) or 1.22 (1.13-1.32), respectively (pinteraction = 0.092).
Conclusion:
Even in the absence of CVRFs, elevated triglycerides and hsCRP were significantly associated with an increased risk of CHD. These results highlight the importance of residual risk assessment using those biomarkers in individuals deemed metabolically healthy by conventional standards.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Angina II: Classification
Coronary Artery Disease V: Interprofessional Care